Wakamoto Pharmaceutical Co., Ltd. Financial Overview
Wakamoto Pharmaceutical Co., Ltd.'s market cap is currently ¥9.75B. The company's EPS TTM is ¥-0.74; its P/E ratio is 135.19; and it has a dividend yield of 1.07%. Wakamoto Pharmaceutical Co., Ltd. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
